• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24040 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2001     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [The establishment of a Danish early warning system for emerging technologies. Report from a pilot project]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [The efficacy of rehabilitative interventions and pharmacological treatments for children aged 2 to 12 years with autism spectrum disorder (ASD)]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [The efficacy of 'Radioguided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized controlled trial]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [The effects of tangible and intangible incentives on health behaviour]
2010     Norwegian Knowledge Centre for the Health Services (NOKC) [The effects of school health services for children and young people's health and growing up conditions]
2005     Finnish Office for Health Care Technology Assessment (Finohta) [The effects of preventive home visits on the functional capacity of older people. A technology assessment based on systematic literature reviews.]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence]
2011     Norwegian Knowledge Centre for the Health Services (NOKC) [The effects of group education on patients and their next of kin]
2000     Finnish Office for Health Care Technology Assessment (Finohta) [The effects of extending the use of mammography screening: a report on the cost-effectiveness of breast cancer screening in 60 to 69 year-old women]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [The effects and costs of cranberry use to prevent clinical urinary tract infections in nursing home residents]
2012     Norwegian Knowledge Centre for the Health Services (NOKC) [The effectiveness of primary interventions to prevent the use of tobacco, alcohol and other drugs among children and adolescents]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of occupational therapy for persons with moderate and severe dementia]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of occupational therapy for persons with moderate and severe dementia]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personnel]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personal]
2012     Norwegian Knowledge Centre for the Health Services (NOKC) [The effectiveness of health promotion and preventive interventions on nutrition, physical activity, obesity, and sexual health in children and adolescents]
2005     Finnish Office for Health Care Technology Assessment (Finohta) [The effectiveness of family interventions. A systematic literature review on controlled trials]
2002     Basque Office for Health Technology Assessment (OSTEBA) [The effectiveness and safety of different forms of treating prostate cancer]
2009     Norwegian Knowledge Centre for the Health Services (NOKC) [The effect of rehabilitation on social and community participation]
2014     Norwegian Knowledge Centre for the Health Services (NOKC) [The effect of infection control interventions in day-care facilities and schools]
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [The economic analysis of robotic surgery for prostate cancer]
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [The disease burden of seasonal influenza and the effectiveness of seasonal influenza vaccination in Korea]
2009     Norwegian Knowledge Centre for the Health Services (NOKC) [The diagnostic accuracy of infrared tympanic, oral, axillary and temporal thermometry, compared with rectal readings when identifying fever in adult hospitalized patients]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [The DExamethasone for Cardiac Surgery (DECS) trial: a large but simple trial to quantify the cost-effectiveness of dexamethasone in patients undergoing cardiac surgery]
2011     Basque Office for Health Technology Assessment (OSTEBA) [The development of the set of basic data on specialised ambulatory care (SBD-SAC) of Osakidetza. Pilot scheme in three hospitals]
2014     Basque Office for Health Technology Assessment (OSTEBA) [The development and piloting of a multidisciplinary collaborative program for the comprehensive care of patients diagnosed with heart failure (HF) – PROMIC]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of ST analysis of the fetal electrocardiogram as compared to fetal blood sampling for intrapartum fetal monitoring: a randomised controlled trial]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of NT-pro-brain natriuretic peptide (NT-proBNP) guided therapy of chronic heart failure]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2008     Center for Medical Technology Assessment (CMT) [The cost of ill-health - a survey of consumption of health care services for different disease groups in the county of Ostergotland, Sweden]
2009     Basque Office for Health Technology Assessment (OSTEBA) [The coordination between primary and specialized healthcare from the point of view of the professionals]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [The coblation technique in tonsillectomy]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [The clinical usefulness and cost-effectiveness of CT coronary angiography for the diagnosis of ischemic heart disease in patients with chest pain]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [The clinical effectiveness and economic analysis of bariatric surgery for severe obesity]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [The Benozzi® method (pilocarpine eye drops) for the treatment of presbyopia]
2014     Basque Office for Health Technology Assessment (OSTEBA) [The application of GRADE in the development of a CPG on childhood asthma]
1998     Finnish Office for Health Care Technology Assessment (Finohta) [The annual costs of medical technology]
2005     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The 13C-urea breath test for detection of helicobacter pylori: potential applications in Quebec ]
2008     Committee for New Health Technology Assessment (CNHTA) [TGFBR2 gene mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [TGFBR1 gene mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [TGFB1 gene, mutation[sequencing]]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezepelumab (severe asthma) - Benefit assessment according to § 35a SGB V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (cystic fibrosis) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 6 to < 12 years, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 6 to < 12 years, F508del mutation, heterozygous) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, heterozygous) - Benefit assessment according to §35a Social Code Book V]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Testing of a method for assessing the internal validity of guideline recommendations, using the example of evidence-based guidelines on preoperative diagnostics]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Testicular cancer: does regular screening for men from the age of 16 lead to better treatment outcomes?]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Terminal care: systematic review of organisational models in palliative care and survey of health professionals regarding the situation of palliative care in a region of the Basque Country]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Teriparatide in biphosphonate-resistant osteoporosis and high fracture risk]
2005     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Teriparatide (parathyroid hormone) for treaing osteoporosis in women in post-menopause]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teriflunomide (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teriflunomide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tepotinib (NSCLC) - Benefit assessment according to §35a Social Code Book V]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Tenofovir alafenamide in patients with HIV diagnosis]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tenofovir alafenamide (chronic hepatits B) - Benefit assessment according to §35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tenofovir alafenamide (chronic hepatitis B) - Benefit assessment according to §35a Social Code Book V]
2022     Basque Office for Health Technology Assessment (OSTEBA) [Temporary percutaneous circulatory support devices for the treatment and prevention of cardiogenic shock: analysis of efficacy, effectiveness and safety]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Temperature-controlled radiofrequency tissue ablation in obstructive sleep apnea]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Temozolomide for anaplastic oligodendroglioma]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telotristat ethyl (carcinoid syndrome diarrhoea) - Benefit assessment according to §35a (1), Sentence 11, Social Code Book V]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Telephone-based counselling and home care as strategies to reduce the frequentation rate to hospital emergencies services: a review]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Telepathology: Guidelines and Technical Standards, Literature Review]
2007     Canary Health Service [Teleneurology vs. face-to-face consultation. Systematic review of their effectiveness and cost-effectiveness]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telemonitoring using active cardiac implantable devices in ventricular tachyarrhythmia and heart failure]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring multi-pathological chronic patients with heart or lung disease. Evaluation of the implementation in Primary Care]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring in patients with heart failure or chronic obstructive disease. Systematic review of the literature]
2022     Austrian Institute for Health Technology Assessment (AIHTA) [Telemonitoring in Austrian diabetes care: a systematic analysis of evaluation methodologies]
1999     Andalusian Health Technology Assessment Area (AETSA) [Telemedicine. Applications in emergencies - systematic review]
2021     Canary Health Service [Telemedicine for the management of consultations, evaluations and therapeutic management in neurological diseases]
2008     Andalusian Health Technology Assessment Area (AETSA) [Telemedicine for monitoring of chronic diseases: Diabetes mellitus]
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Telemedical prehospital diagnostic of patients with acute myocardial infarction - a new IT-based concept]
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Telehealth: clinical guidelines and technological standards for telerehabilitation]
2008     Andalusian Health Technology Assessment Area (AETSA) [Teledermatology. Systematic review and economic assessment]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telaprevir - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2009     Committee for New Health Technology Assessment (CNHTA) [TEL/AML1 rearrangement, quantitative [real-time RT-PCR]]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Teduglutide in short bowel syndrome]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Teduglutide for the treatment of patients with short bowel syndrome]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teduglutide (short bowel syndrome; patients from the age of 1 year) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teduglutide - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teclistamab (multiple myeloma) – Benefit assessment according to §35a Social Code Book V]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Technology assessment of wound care with SEPS]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Tecar therapy for the management of osteoarticular lesions]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tebentafusp (uveal melanoma) – Benefit assessment according to §35a Social Code Book]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tebentafusp (uveal melanoma) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Tearlab® osmolarity system for dry eye]
2013     Norwegian Knowledge Centre for the Health Services (NOKC) [Task sharing for selected health services in hospitals]
2013     Norwegian Knowledge Centre for the Health Services (NOKC) [Task sharing for selected health services in hospitals]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tasimelteon (non-24-hour sleep-wake disorder in totally blind adults) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Targeted therapies (vemurafenib, dabrafenib, cobimetinib, trametinib) and immunotherapies (ipilimumab, nivolumab, pembrolizumab) for the first-line treatment of advanced (unresectable and metastatic) melanoma]
2024     Haute Autorite de sante (HAS) [Targeted next generation sequencing gene panel in the medical management of chronic lymphocytic leukemia]
2023     Canary Health Service [Targeted muscle reinnervation in individuals with amputated limbs]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Targeted lung denervation using catheter ablation for chronic obstructive pulmonary disease - Addendum to Commission H16-01]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Targeted lung denervation by catheter ablation in chronic obstructive lung disease: Assessments according to §137h SGB V]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Target next generation sequencing-based gene panels in tumors of unknown origin]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Target group-specific approach to insured persons during health check-ups]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Tandem mass spectrometry and neonatal blood screening in Quebec]